Drug Profile
Monoclonal antibody 1H10-doxorubicin conjugate
Latest Information Update: 08 May 1997
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 08 May 1997 New profile
- 08 May 1997 No-Development-Reported for Cancer in Taiwan (Unknown route)